Product Information
BORTEZOMIB 3.5 MG VIAL is a generic product labeled by NorthStar Rx LLC, priced at $43.3460 per EA under NDC 72603027001. Its NADAC has been published 7 times since Mar 5, 2025.
Strength
3.5 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603027001
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/19/2025
Active Ingredients
BORTEZOMIBApproval Type
Generic (ANDA)
FDA Application
ANDA202963On Market Since
11/1/2024
Pharmacological Classes
Price Statistics
The NADAC for BORTEZOMIB 3.5 MG VIAL has been published 7 times since Mar 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.3460 per EA |
|---|---|
| All-time high | $43.3460 (Apr 16, 2025) |
| All-time low | $43.3460 (Mar 5, 2025) |
| Median price | $43.3460 |
| Average price | $43.3460 |
| Largest weekly change | 0.0% (Mar 12, 2025) |
| Weeks tracked | 7 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BORTEZOMIB 3.5 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BORTEZOMIB 3.5 MG VIAL, manufactured by NorthStar Rx LLC, is $43.3460 per EA (NDC 72603027001), effective Apr 16, 2025.
How has the price of BORTEZOMIB 3.5 MG VIAL changed over time?
Over the history we have for it, the NADAC for BORTEZOMIB 3.5 MG VIAL has held within roughly two percent of its current level. It has been tracked across 7 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for BORTEZOMIB 3.5 MG VIAL?
Since Mar 5, 2025, the NADAC for BORTEZOMIB 3.5 MG VIAL has ranged from a low of $43.3460 (Mar 5, 2025) to a high of $43.3460 (Apr 16, 2025), with a median of $43.3460 per EA.
Are there cheaper alternatives to BORTEZOMIB 3.5 MG VIAL?
8 NADAC-published products share the same active ingredient, strength, and dosage form as BORTEZOMIB 3.5 MG VIAL, but none are currently priced below it.
Who manufactures BORTEZOMIB 3.5 MG VIAL?
BORTEZOMIB 3.5 MG VIAL (NDC 72603027001) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification